US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist
  • 4.940
  • +0.040+0.82%
Trading Nov 22 13:17 ET
95.45MMarket Cap-4258P/E (TTM)

Nuvectis Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
25.89%-2.4M
26.03%-3.02M
8.77%-4.36M
-17.66%-15.95M
-9.50%-3.85M
26.67%-3.24M
-60.56%-4.08M
-55.30%-4.78M
-42.67%-13.56M
-229.52%-3.52M
Net income from continuing operations
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
-48.06%-19.09M
-196.15%-6.7M
Change In working capital
-60.77%590K
-78.37%146K
30.38%-1.48M
-58.08%1.6M
-42.48%1.55M
68.23%1.5M
30.81%675K
-637.02%-2.13M
155.62%3.82M
167.39%2.7M
-Change in payables and accrued expense
-60.03%546K
-71.74%78K
28.30%-1.29M
-69.86%1.25M
-25.27%1.41M
-6.05%1.37M
6.15%276K
-432.47%-1.8M
161.20%4.14M
71.27%1.88M
-Change in other current assets
-68.12%44K
-82.96%68K
41.77%-191K
209.97%353K
-82.31%144K
124.64%138K
55.86%399K
60.53%-328K
-252.75%-321K
994.51%814K
Cash from discontinued investing activities
Operating cash flow
25.89%-2.4M
26.03%-3.02M
8.77%-4.36M
-17.66%-15.95M
-9.50%-3.85M
26.67%-3.24M
-60.56%-4.08M
-55.30%-4.78M
-42.67%-13.56M
-229.52%-3.52M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
107.25%1.46M
-87.35%1.67M
1,763.49%4.7M
-45.75%15.09M
800.00%917K
-95.15%703K
2,386.33%13.22M
-98.20%252K
82.41%27.81M
-131K
Net common stock issuance
33.84%1.51M
-47.06%1.73M
--4.85M
-83.41%5.29M
--901K
-92.91%1.13M
--3.26M
--0
--31.88M
--0
Proceeds from stock option exercised by employees
--0
--0
--0
--11.19M
--0
--14K
--10.48M
--702K
--0
--0
Net other financing activities
88.56%-50K
89.48%-55K
66.00%-153K
65.74%-1.39M
112.21%16K
68.49%-437K
9.52%-523K
77.19%-450K
---4.07M
---131K
Cash from discontinued financing activities
Financing cash flow
107.25%1.46M
-87.35%1.67M
1,763.49%4.7M
-45.75%15.09M
800.00%917K
-95.15%703K
2,386.33%13.22M
-98.20%252K
82.41%27.81M
---131K
Net cash flow
Beginning cash position
-26.36%18.12M
25.83%19.46M
-4.34%19.13M
248.19%19.99M
-6.69%22.06M
81.26%24.6M
-7.34%15.47M
248.19%19.99M
--5.74M
247.19%23.64M
Current changes in cash
62.73%-947K
-114.76%-1.35M
107.47%338K
-106.08%-867K
19.58%-2.93M
-125.24%-2.54M
392.60%9.13M
-141.32%-4.53M
148.19%14.25M
-241.80%-3.65M
End cash Position
-22.17%17.17M
-26.36%18.12M
25.83%19.46M
-4.34%19.13M
-4.34%19.13M
-6.69%22.06M
81.26%24.6M
-7.34%15.47M
248.19%19.99M
248.19%19.99M
Free cash flow
25.89%-2.4M
26.03%-3.02M
8.77%-4.36M
-17.66%-15.95M
-9.50%-3.85M
26.67%-3.24M
-60.56%-4.08M
-55.30%-4.78M
-42.67%-13.56M
-229.52%-3.52M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 25.89%-2.4M26.03%-3.02M8.77%-4.36M-17.66%-15.95M-9.50%-3.85M26.67%-3.24M-60.56%-4.08M-55.30%-4.78M-42.67%-13.56M-229.52%-3.52M
Net income from continuing operations 29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M-48.06%-19.09M-196.15%-6.7M
Change In working capital -60.77%590K-78.37%146K30.38%-1.48M-58.08%1.6M-42.48%1.55M68.23%1.5M30.81%675K-637.02%-2.13M155.62%3.82M167.39%2.7M
-Change in payables and accrued expense -60.03%546K-71.74%78K28.30%-1.29M-69.86%1.25M-25.27%1.41M-6.05%1.37M6.15%276K-432.47%-1.8M161.20%4.14M71.27%1.88M
-Change in other current assets -68.12%44K-82.96%68K41.77%-191K209.97%353K-82.31%144K124.64%138K55.86%399K60.53%-328K-252.75%-321K994.51%814K
Cash from discontinued investing activities
Operating cash flow 25.89%-2.4M26.03%-3.02M8.77%-4.36M-17.66%-15.95M-9.50%-3.85M26.67%-3.24M-60.56%-4.08M-55.30%-4.78M-42.67%-13.56M-229.52%-3.52M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 107.25%1.46M-87.35%1.67M1,763.49%4.7M-45.75%15.09M800.00%917K-95.15%703K2,386.33%13.22M-98.20%252K82.41%27.81M-131K
Net common stock issuance 33.84%1.51M-47.06%1.73M--4.85M-83.41%5.29M--901K-92.91%1.13M--3.26M--0--31.88M--0
Proceeds from stock option exercised by employees --0--0--0--11.19M--0--14K--10.48M--702K--0--0
Net other financing activities 88.56%-50K89.48%-55K66.00%-153K65.74%-1.39M112.21%16K68.49%-437K9.52%-523K77.19%-450K---4.07M---131K
Cash from discontinued financing activities
Financing cash flow 107.25%1.46M-87.35%1.67M1,763.49%4.7M-45.75%15.09M800.00%917K-95.15%703K2,386.33%13.22M-98.20%252K82.41%27.81M---131K
Net cash flow
Beginning cash position -26.36%18.12M25.83%19.46M-4.34%19.13M248.19%19.99M-6.69%22.06M81.26%24.6M-7.34%15.47M248.19%19.99M--5.74M247.19%23.64M
Current changes in cash 62.73%-947K-114.76%-1.35M107.47%338K-106.08%-867K19.58%-2.93M-125.24%-2.54M392.60%9.13M-141.32%-4.53M148.19%14.25M-241.80%-3.65M
End cash Position -22.17%17.17M-26.36%18.12M25.83%19.46M-4.34%19.13M-4.34%19.13M-6.69%22.06M81.26%24.6M-7.34%15.47M248.19%19.99M248.19%19.99M
Free cash flow 25.89%-2.4M26.03%-3.02M8.77%-4.36M-17.66%-15.95M-9.50%-3.85M26.67%-3.24M-60.56%-4.08M-55.30%-4.78M-42.67%-13.56M-229.52%-3.52M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data